Safety of capecitabine (X) compared to fluorouracil/leucovorin (5-FU/LV) for the adjuvant treatment of elderly colon cancer patients (pts)

E Diaz-Rubio, H Burris, JY Douillard… - Journal of Clinical …, 2004 - ascopubs.org
3737 Background: The improved safety profile of the oral fluoropyrimidine X (Xeloda) versus
bolus 5-FU/LV has been demonstrated in over 3000 pts in 3 large randomized trials in 1st …
被引用次数：17 相关文章

[引用][C] Safety of capecitabine (X) compared to fluorouracil/leucovorin (5-FU/LV) for the adjuvant treatment of elderly colon cancer patients (pts).

E Diaz-Rubio, H Burris, J Douillard, F Coxon… - 2004 - ora.ox.ac.uk
Safety of capecitabine (X) compared to fluorouracil/leucovorin (5-FU/LV) for the adjuvant
treatment of elderly colon cancer patients (pts). - ORA - Oxford University Research Archive …